Mucin glycoproteins are major constituents of the glycocalyx that covers mucosal epithelium. Two broad classes of mucins exist: membrane-associated and secretory. Of the secreted mucins, those with cysteine-rich regions are thought to polymerize through disulphide bonds. Among these gel-forming mucins are MUC2, MUC5AC, MUC5B and possibly MUC6. MUC7 lacks cysteine-rich domains and is thought to be secreted as a soluble monomer. Incomplete sequence information prevents classification of other mucins. Tandem repeats of amino acids rich in serine, threonine and proline are a common element in mucin core proteins, giving rise to relatively rigid, linear molecules with great potential for glycosylation. Ten distinct mucin genes have been identified in humans so far. Patterns of expression vary greatly. While MUC9, or oviductin, appears to be restricted to oviduct, the transmembrane mucin MUC1 is widely expressed. Proven functions for the different mucins are largely unknown, although potential functions are addressed in this review. Genetic and protein sequence information and expression profiles are also summarized, followed by a description of mucin assembly. Special attention is given to mucin expression in male and female reproductive tracts.
Introduction
The reproductive tract mucosa must permit gamete transport and, in the case of the uterus, also embryo implantation and placental development. These processes, however, occur relatively infrequently. In contrast, reproductive tract mucosa must persistently provide protection against infection. Part of the protective functions of these tissues is provided by specialized lymphoid tissues along with a standard complement of lymphocytes and phagocytic cells (Parr and Parr, 1986 ). Nonetheless, a major barrier to infection prevents pathogenic colonization, and mucin glycoproteins expressed at the apical surfaces of epithelia are believed to play major roles as barrier molecules in mucosa. In addition to providing lubrication of epithelial surfaces and preventing tissue dehydration (Jentoff, 1990; Devine and McKenzie, 1992) , evidence suggests that mucins may also protect proteins and cells from proteolysis (Jentoff, 1990) , protect tissues from microbial attack (Lamblin and Roussel, 1993) , modulate cell attachment Ligtenberg et al., 1992; Kemperman et al., 1994; Wesseling et al., 1995; Hey and Aplin, 1996; Zhang et al., 1996) , and inhibit immune cell function (Fung and Longenecker, 1991; Ogata et al., 1992; Gimmi et al., 1996; see Table I ). In the discussion below, we will first consider basic aspects of the structure and assembly of mucin glycoproteins, as well as their proposed functions. The expression of mucins and mucin genes in the mammalian reproductive tract as well as potential specialized functions that these glycoproteins perform in these tissues will be considered.
Mucin genes and proteins
Mucins are defined as proteins that are heavily substituted with oligosaccharides in O-linkage to serine or threonine residues. However, while all mucins described are O-glycosylated glycoproteins, not all O-glycosylated proteins are mucins (Van Klinken et al., 1995) . Mucin core proteins typically contain a series of tandem repeat domains enriched in serine, threonine and proline residues (see Table II ). Except for MUC5B, many human mucin genes are polymorphic. Allelic variation observed in these genes is normally due to variable numbers of tandem repeats (Debailleul et al., 1998) . The nomenclature adopted for mucin genes is MUC followed by a number reflecting the order in which the particular mucin gene was discovered. A total of 10 mucin genes have been unequivocally identified; however, there are probably at least several more (see below). MUC2, MUC5AC, MUC5B and MUC6 are all located on chromosome 11p15 and their proteins have cysteine-rich domains similar to those in von Willebrand factor (vWF) that may participate in intermolecular disulphide bonds, ultimately forming the viscous gel covering most luminal surfaces (Desseyn et al., 1997a; Gipson and Inatomi, 1997; Keates et al., 1997) . Cysteines within the C-termini of these gel-forming mucins are conserved in number and in spacing. This feature is shared with vWF and growth factors such as transforming growth factor β (TGFβ) and is predicted to form a specific tertiary structure. Referred to as a cystine knot, this putative structure would result from the formation of three intramolecular disulphide bonds among six conserved C-terminal cysteines (McDonald and Hendrickson, 1993; Meitinger et al., 1993) . The functional significance of this structure is unknown. Alternatively, MUC7 is secreted as a soluble, non-gel-forming monomer (Bobek et al., 1993) . Further information is needed to categorize accurately MUC3, MUC4 and MUC8 genes and their proteins. A transmembrane sialomucin complex (SMC) composed of two subunits, ascites sialoglycoprotein (ASGP)-1 and -2, has been identified in rat, and similarities exist between MUC1 and SMC with regard to protein structure and processing (Gendler and Spicer, 1995; Rossi et al., 1996) ; See Note added in proof. MUC1 is one of the few known transmembrane mucins in humans. Forms of MUC1 exist that lack either the ectodomain (Zrihan-Licht et al., 1994) or the cytoplasmic tail (Williams et al., 1990) ; however, it is not clear whether these result from alternative mRNA splicing events or proteolytic cleavage events. The molecular weight of the core protein of MUC1 is calculated to be 120-225 kDa, while the mature glycosylated protein has a range of 250-500 kDa (Lancaster et al., 1990; Gendler et al., 1991; Gendler and Spicer, 1995) . A MUC1 molecule can contain 20-125 tandem repeats and may be composed of 60-80% carbohydrate (Gendler et al., 1991; Gipson and Inatomi, 1997) . Other names for MUC1 include polymorphic epithelial mucin (PEM), episialin, peanut lectin-binding urinary mucin, DF3 antigen (recognized by DF3 monoclonal antibody), epithelial membrane antigen (EMA) and HMFG (human milk fat globule) antigen (Gum et al., 1994) . The genomic sequence of MUC1 spans 4-7 kilobases, contains seven exons for a transcript of 2.5-8.8 kilobases, and is located on chromosome 1q21-24 in humans (Lancaster et al., 1990) . Most of the mucins discovered after MUC1 have been classified as secretory because of their expression by simple secretory epithelia, although the complete cDNA sequences are known only for MUC2, MUC7 and MUC9.
MUC2 initially was cloned from a human intestine cDNA library (Gum et al., 1989 (Gum et al., , 1994 and has been detected in colon, small intestine and airways (Gum et al., 1994) . The complete cDNA sequence of 15 563 base pairs encodes more than 5100 amino acids with four 350-amino acid, cysteine-rich repetitive elements (D1-D4) similar to the four D-domains of vWF (Gum et al., 1994; see Figure 1 ). Following the three N-terminal D-domains is a mucin-like domain defined by Thr/Ser/Pro(TSP)-rich irregular repeats and a variable-length region of 23-amino acid tandem repeats (see Figure 1) . The TSP-rich region and variable-length region together constitute more than half the length of MUC2 protein encoded by the most common allelic form of the gene, which contains approximately 100 tandem repeats (Gum et al., 1994) . Transcripts of 14-16 kilobases have been reported for MUC2 due to allelic variation in the number of tandem repeats (Debailleul et al., 1998) .
Partial cDNA sequences have been reported for MUC3, cloned from a human small intestine library and localized to chromosome 7q22 (Gum et al., 1990; Fox et al., 1992; Van Klinken et al., 1997) . Over 2 kilobases of continuous cDNA sequence encoding 650 amino acids was found to contain a mucin-like, non-repetitive region, rich in serine (20%), threonine (27%) and proline (11%), flanked by two types of tandem repeat domains (Yan et al., 1990) . cDNA clones of the 177-base pair (59-amino acid) and 51-base pair (17-amino acid) tandem repeat regions indicate that these regions are at least 2.3 and 4 kilobases in length respectively (Van Klinken et al., 1997) . Potential N-glycosylation sites were found occasionally within both regions, but not within the consensus sequence for either (Van Klinken et al., 1997) . Also, one cysteine was found between the non-repetitive region and the 17-amino acid tandem repeat region (Van Klinken et al., 1997) . In addition to small intestine, MUC3 has been detected in colon and gallbladder (Gum et al., 1990; Van Klinken et al., 1997) .
Cloned from a tracheobronchial cDNA library (Porchet et al., 1991) and localized to chromosome 3q29 (Seregni et al., 1997) , MUC4 is distinguished from other mucins by tandem repeats of 48 base pairs, encoding a repeating peptide of 16 amino acids rich in serine (19%), threonine (25%) and proline (13%) (Porchet et al., 1991) , and also by tandem repeats of 15 base pairs, perfectly conserved and extending for at least 4 kilobases (Porchet et al., 1995) . A recently obtained 5′ sequence revealed a signal peptide similar to that of the SMC subunit ASGP-1 (Nollet et al., 1998) . In-situ hybridization and Northern blot analysis demonstrated expression of MUC4 in bronchus, prostate, endocervix (Porchet et al., 1995) and conjunctival epithelium (Gipson and Inatomi, 1997) , with weak expression in small intestine, colon and gastric epithelium (Porchet et al., 1995) . The MUC4 gene is highly polymorphic in humans due to variable numbers of tandem repeats (Debailleul et al., 1998) .
Peptide fragments and partial cDNA clones encoding MUC5AC have been isolated and analysed (Rose et al., 1989; Meerzaman et al., 1994; Guyonnet-Duperat et al., 1995; Lesuffleur et al., 1995) . According to biochemical and molecular analysis, MUC5AC appears to have mucin-like, TSP-rich, glycosylated domains interrupted by Cys-rich, poorly glycosylated domains (Rose et al., 1989; Guyonnet-Duperat et al., 1995) . The TSP-rich regions consist of either repetitive sequences of 24-base pair (8-amino acid) tandem repeats or non-repetitive sequences (Guyonnet-Duperat et al., 1995) . The Cys-rich domains are 130 amino acids each, with ten conserved cysteines per domain (Guyonnet-Duperat et al., 1995;  see Figure 1 ). Three different C-termini have been reported, including a 436-base pair cDNA clone, containing tandem repeats of 24 base pairs (8-amino acids) followed by nine stop codons and a polyadenylation sequence (Guyonnet-Duperat et al., 1995) . Independently, two other groups isolated cDNA clones greater than 3 kilobases that are 98.6% identical in nucleotide sequence, but due to single amino acid differences, changes in reading frame cause the deduced peptides to have four regions of low similarity, one being an additional C-terminal sequence (Meerzaman et al., 1994; Lesuffleur et al., 1995; see Figure 1 ). In spite of these differences, both sequences are cysteine-rich and display three short conserved sequences and potential N-glycosylation sites that may play a role in polymerization (Meerzaman et al., 1994; Lesuffleur et al., 1995) . Cysteine-rich sequences induce polymerization by forming disulphide bonds. Expression of MUC5AC has been detected by in-situ hybridization and Northern blot analysis most strongly in bronchial epithelium and submucosal glands, surface mucous cells of gastric epithelium (Porchet et al., 1995) , and conjunctival goblet cells of the eye (Gipson and Inatomi, 1997) , with moderate expression in endocervix and weak expression in gallbladder (Porchet et al., 1995) .
Genomic sequences encoding over 20 kb of MUC5B transcript have been reported (Troxler et al., 1995; Desseyn et al., 1997a,b; Keates et al., 1997; Nielsen et al., 1997) . This mucin was initially referred to as human gallbladder mucin or high-molecular weight salivary mucin MG1. MUC5B contains a very large central exon of 10 713 base pairs encoding a peptide of 3570 amino acids (Desseyn et al., 1997b) . The peptide contains four 528-amino acid super-repeats, each composed of three subdomains: 11 irregular 87-base pair repeats, 111 amino acids of mucin-like, TSP-rich nonrepetitive sequence, and a cysteine-rich subdomain of 108 amino acids with similarity to cysteine-rich sequences in MUC2 and MUC5AC (Desseyn et al., 1997b; see Figure 1 ). This super-repeat is the largest repeat known of all mucin genes (Desseyn et al., 1997b) . Two different C-termini have been published for MUC5B. Initially, 10 690 base pairs of genomic sequence was described encoding an 808-amino acid peptide that contains several regions similar to corresponding sequences in other 11p15 mucin genes and in vWF (Desseyn et al., 1997a; see Figure 1 ). Subsequently, genomic clones were reported encoding 983 amino acids of C-terminal sequence (Keates et al., 1997) . The two prospective C-termini display overall similarity to each other, with differences in the number of potential N-glycosylation sites and in vWF C-like (similar to one of the cysteine-rich C-domains of vWF) domains (Desseyn et al., 1997a; Keates et al., 1997) . The MUC 11p15-type subdomain shows similarity with respect to cysteine residues in MUC2, MUC5AC and MUC5B (Desseyn et al., 1997a) . Several domains in these mucins display cysteines conserved in human vWF, although representation varies between prospective C-terminal sequences for MUC5AC and MUC5B (Desseyn et al., 1997a) . MUC5B expression has been detected strongly in all mucous cells of salivary glands (Troxler et al., 1995; Nielsen et al., 1997) , bronchial submucosal glands, and gallbladder epithelium and glands, with weak expression in endocervix (Porchet et al., 1995) . Biochemical studies of MUC5B demonstrated that the mature glycoprotein is >1000 kDa, comprised of approximately 15% protein and 78% carbohydrate, and probably exists as an oligomer (Bobek et al., 1993) . Also, the MUC5B gene is unique among the human mucins since it does not appear to be polymorphic (Debailleul et al., 1998) .
MUC6 (human gastric mucin) was partially cloned from a gastric cDNA library (Toribara et al., 1993) . cDNA sequences include a tandem repeat region of 507-base pairs encoding an amino acid sequence with repeat units rich in threonine (31%), serine (18%) and proline (15%) (Yao et al., 1997) , in addition to a C-terminal sequence beginning with a series of 169-amino acid tandem repeats followed by a 270-amino acid mucin-like, TSP-rich (61%) non-repetitive region, ending with a Cys-rich region similar to the extreme C-terminus of vWF, based on conservation of the 11 invariant cysteine residues of the putative cystine knot (Toribara et al., 1997; see Figure 1 ). Within the gastrointestinal tract, MUC6 is expressed in mucous neck cells of the fundus, submucosal glands in the antrum and cardia, and Brunner's glands of the duodenum, with weak expression in terminal ileum and right colon (Toribara et al., 1993 (Toribara et al., , 1997 . MUC6 has also been detected in gallbladder, pancreas, seminal vesicles and the female reproductive tract (Toribara et al., 1997) .
MUC7, or low-molecular weight human salivary mucin MG2, is a 120-150 kDa glycosylated protein with a 39 kDa core protein. MUC7 was cloned initially from a human submandibular gland cDNA library and mapped to chromosome 4 (Bobek et al., 1993) . The protein is composed of 30% protein and 68% carbohydrate, and exists as a soluble, non-gel-forming monomer secreted by mucous acinar cells of sublingual, submandibular and labial salivary glands. The first 20 encoded amino acids of MUC7 are hydrophobic and are thought to constitute the signal peptide. The tandem repeat domain consists of 23-amino acid (69-base pair) repeat units rich in threonine (22%), serine (17%) and proline (35%) and is flanked by unique 5′ and 3′ regions containing four and one potential N-glycosylation sites respectively. Although six tandem repeats were found in the cloned MUC7 sequence, the gene may be polymorphic, as suggested by Southern blot analysis. Two cysteines are present in the unique 5′ region of MUC7 and may participate in an intramolecular disulphide bond since MUC7 exists as a monomer. Even though part of the MUC7 cDNA contains a start codon with a strong Kozak consensus sequence for translation initiation, as well as an in-frame stop codon, there is some doubt that the actual 5′ end of the mRNA has been determined. C-terminal sequence information for the protein has been published for MUC8, a major airway mucin originally cloned from a normal human tracheal expression library (Shankar et al., 1997) . A total of 942 base pairs of continuous cDNA sequence includes a region of near-perfect, 41-base pair tandem repeats that encode two types of peptide repeats consisting of 41 and 13 amino acids, followed by a unique, non-repetitive sequence of 30 amino acids. Northern blot analysis and immunohistochemical studies demonstrate that MUC8 is expressed in stomach, submucosal glands of the trachea, testis, placenta, endometrium and cervix, with weak-to-undetectable levels in epididymis, seminal vesicle, ovary, Fallopian tube and uterus (D'Cruz et al., 1996) . The MUC8 gene was localized to chromosome 12q24.3 (Shankar et al., 1997) .
MUC9, which encodes the oviduct-specific glycoprotein oviductin, is 2216 base pairs in length (Arias et al., 1994; Lapensee et al., 1997) . The cDNA has an open reading frame of 1962 base pairs encoding a 654-amino acid core protein with a calculated molecular mass of 72.9 kDa (120 kDa when glycosylated) (Arias et al., 1994) . The last 510 base pairs of oviductin cDNA contain three divergent 45-base pair tandem repeats followed by two partial repeats, encoding a peptide repeat unit of 15 amino acids composed of approximately 20% threonine, 7% serine and 11% proline (Arias et al., 1994) . Similar repeats were found also in C-termini of hamster, mouse and baboon oviductin (Arias et al., 1994; Suzuki et al., 1995) . Five cysteine residues are found widely spaced within the 484 amino acids preceding the tandem repeats, and a string of 11 hydrophobic residues at the N-terminal end of the protein may represent a signal peptide (Arias et al., 1994) .
Several mucins have been identified in species other than human beyond the orthologues of mucins already mentioned. Porcine submaxillary mucin contains a large tandem repeat domain of 130-200 repeats of 81 amino acids flanked by mucin-like regions rich in threonine, serine and proline (reviewed in Gendler and Spicer, 1995) . Several N-glycosylation sites are also present, in addition to a cysteine-rich extreme C-terminus, a feature conserved among secreted mucins such as bovine submaxillary mucin-like protein, and the frog integumentary mucins. Biochemical studies indicate that porcine submaxillary mucin has no secondary structure except for a globular tail formed by disulphide bonds among cysteines. Partial cDNA sequence of bovine submaxillary mucin has been obtained encoding 563 amino acids, 339 of which are mucin-like sequence (39% serine and threonine, 4% proline), followed by a cysteine-rich domain of 244 amino acids (11% cysteine, 12% serine and threonine). This sequence is similar to porcine submaxillary mucin, but the actual C-terminus of bovine submaxillary mucin has yet to be determined, and no biochemical analysis has been performed (reviewed in Gendler and Spicer, 1995) .
The frog integumentary mucins (FIM) are produced by merocrine mucous glands within the skin of Xenopus laevis (Gendler and Spicer, 1995) . FIM-B.1, the only mucin gene whose tandem repeat sequence is divided by introns, is composed mostly of acidic repeats of 11 amino acids with many O-glycosylation sites. Interrupting the repeats is a region similar to the short conserved region seen in the complement receptor family that contains four conserved Cys-Phe-Tyr-GlyTrp-Pro. It has been suggested that this short conserved region serves to disrupt bacterial adhesion to the host by competitive inhibition, as this region is an attachment site for many bacteria (Gendler and Spicer, 1995) . FIM-A.1 (spasmolysin) consists of a 43 kDa core protein (130 kDa mature glycosylated form) that contains 13 Thr-rich repeats of nine amino acids, seven repeats of sequence Glu-Thr-Thr-Thr, and four P-domains that are strings of approximately 50 amino acids with six invariant Cys forming three intramolecular disulphide bridges (Gendler and Spicer, 1995) . Spasmolysins generally inhibit gastrointestinal motility and induce gastric secretion, and stimulate growth of colon and breast tumours in vitro. Partial sequencing of FIM-C.1 reveals three semi-repetitive Thr-rich clusters and six P-domains. The gene is polymorphic due to variable lengths of Thr-rich domains, and is expressed in cone cells of mucous glands, the only place lacking FIM-A.1.
Mucin assembly
As mentioned above, mucin glycoproteins are heavily substituted with O-linked oligosaccharides that may constitute most of the mass of the glycoprotein (Jentoff, 1990; Carraway and Hull, 1991) . The constituent O-linked oligosaccharides are linked through N-acetylgalactosamine at their reducing termini to proteins via the hydroxyl groups of serine or threonine residues. Hundreds of O-linked oligosaccharide structures have been determined by various techniques including glycosidase sensitivity, nuclear magnetic resonance (NMR) and mass spectrometry. The core N-acetylgalactosamine is substituted with galactose in either β1→3 or β1→4 linkage. Additional modifications give rise to structures that are branched and variously substituted with N-acetylglucosamine, galactose, fucose, sialic acids or sulphate Kobata and Takasaki, 1992) . Some of these structures are found in a diverse array of cells and tissues, while others are only transiently expressed and highly localized in adult or developing tissues (Muramatsu, 1988) . Many monoclonal antibodies have been generated which contain O-linked oligosaccharide determinants as all or part of their structure. Expression of certain mucin oligosaccharide structures may serve as useful markers of developmental transitions (Muramatsu, 1988) or the presence of certain tumours (Ho and Kim, 1991; Devine and McKenzie, 1992) . In addition, mucin oligosaccharides may present motifs critical for cell recognition processes, e.g. selectin ligands (Lasky, 1992) .
Like other secretory or cell surface proteins, mucin core proteins are synthesized in the rough endoplasmic reticulum and traffic to the Golgi apparatus where the O-glycosylation reactions occur, including the initial addition of the core N-acetylgalactosamine residue Roth et al., 1994; Pimental et al., 1996) . The primary amino acid sequence requirements for O-glycosylation of mucin core proteins appear to be fairly promiscuous and are poorly understood, in spite of a great deal of research to define acceptor site specificities. The linkage serine/threonine residues are usually flanked by proline residues in the -6, -1 or +3 positions (O'Connell et al., 1991) . Multiple UDP-GalNAc:protein GalNAc transferases can glycosylate both serine and threonine residues in synthetic peptides; however, threonines seem to be the preferred sites (Wang et al., 1992; Wandall et al., 1997) . Recent studies reveal that only a limited number of potential acceptor sites in MUC1 tandem repeat regions are glycosylated in vitro (Nishimori et al., 1994) ; however, almost all potential O-glycosylation sites in MUC1 can be O-glycosylated in vivo, although all such sites may not be glycosylated in an individual MUC1 molecule (Müller et al., 1997) . Moreover, the type and degree of O-glycosylation of a given mucin core protein can vary greatly in different cells. For example, MUC2 oligosaccharides are heavily sialylated in the small intestine and heavily sulphated in the large intestine (Karlsson et al., 1997) . Furthermore, tumour cells appear to express underglycosylated forms of mucins relative to normal cells (Ho and Kim, 1991; Devine and McKenzie, 1992) . Following these terminal glycosylation reactions, mucins then transit to the cell surface either for residence at the plasma membrane or secretion. Estimated transit times from the sites of synthesis to the cell surface range from 0.5 to 2.5 h (Linsley et al., 1988; Dohi et al., 1993; Litvinov and Hilkens, 1993; Pimental et al., 1996) .
Secretory mucins are released where they can form extremely large and viscous gels held together by disulphide bonds (Forestner, 1995) . Such mucins are generally cleared by net fluid flow through the lumina of various mucosa (Forestner, 1995) . Integral cell surface mucins are retained at the external surface of the plasma membrane via transmembrane domains of their protein cores . In polarized cells, mucins are primarily expressed at the apical cell surface (Jentoff, 1990; Carraway and Hull, 1991) . While MUC1 is the only human mucin known to be membrane-spanning, a second transmembrane mucin, SMC, has been described in rat (Sheng et al., 1992; Wu et al., 1994; Rossi et al., 1996) . The SMC heterodimer is synthesized as a single peptide precursor that is cleaved into two subunits: ASGP-1, the glycosylated mucin-like portion; and ASGP-2, the membrane-associated part of the heterodimer (Rossi et al., 1996) . Studies of MUC1 indicate that membrane-sorting signals may occur in the transmembrane or membrane-proximal ectodomain sequences of the protein core (Pemberton et al., 1996) . Metabolic half-lives of Muc1 and other cell-associated mucins in normal mouse uterine epithelial cells were estimated to be approximately 16 h (Pimental et al., 1996) . Catabolism of these mucins may, in part, be due to endocytosis and lysosomal degradation; however, a large fraction of such mucins are removed by release of the ectodomain from the cell surface (Boshell et al., 1992; Pimental et al., 1996) . It is possible that this release is via a proteolytic mechanism, but this has not been rigorously demonstrated. Nonetheless, mucin ectodomain release apparently does result in separation from the membrane-spanning region of the protein core (Boshell et al., 1992; Pimental et al., 1996) ; however, these transmembrane domains do not accumulate in cells, suggesting that they are targeted for degradation following separation from the ectodomain. There also is evidence that transmembrane mucins can be recycled after endocytosis Litvinov and Hilkens, 1993) . These observations indicate that at least a subpopulation of mucins can be modified after they are initially assembled and transported to the cell surface.
In spite of the extraordinary resistance of mucins to enzymatic attack, both bacteria (Abdullah et al., 1992) and mammalian tissues (Slomiany et al., 1993) secrete enzymes that have the ability to digest mucins. These enzymes may act on either secreted, soluble mucins or mucin ectodomains as well as cell surface forms. In the case of bacteria, mucin-degrading enzymes may aid in escape from mucus gels or penetration to the cell surface (see below). The physiological function of mammalian-secreted, mucin-degrading enzymes is not clear; however, some data indicate that the products of these digestions bind microbes more effectively than the intact mucins (Slomiany et al., 1993) . Therefore, production of mucin-degrading enzymes may promote antibacterial activities rather than function in mucin catabolism.
Mucin functions
As noted above, mucin glycoproteins are very large, highly hydrated structures. As such, they can function as lubricants and prevent dehydration of luminally disposed cell surfaces (Jentoff, 1990; Devine and McKenzie, 1992) . A number of proteins not classically thought of as mucins, e.g. low-density lipoprotein (LDL) receptor, contain regions heavily substituted with O-linked oligosaccharides. The dense packing of the oligosaccharides protects these regions of proteins from proteolytic attack (Jentoff, 1990) . In classic mucins, this principle is extended. Virtually all of the protein core of soluble mucins and the extracellular domain of transmembrane mucins are substituted with O-linked oligosaccharides, making them extremely resistant to proteolysis.
Mucins have classically been attributed the role of a protectant against bacterial colonization and/or infection (Cohen et al., 1984; Lamblin and Roussel, 1993) . Bacterial access to mucosa comes from the external environment via ingestion, respiration or coital activity. Given the diversity of the organ systems involved, an underlying characteristic holds firmly, that of a luminal epithelial layer which expresses and is covered by a thick gelatinous mucin layer in which bacteria are trapped (Lamblin and Roussel, 1993; Slomiany et al., 1996) . Subsequently, immunological responses such as phagocytosis and outflow from the organ system neutralize and remove bacteria from the host. This process is quite evident in the respiratory system where ciliary beating removes mucin-trapped bacteria from the bronchial passages and trachea and releases them as sputum (Lamblin and Roussel, 1993) . Given the extreme diversity of bacteria present in the environment, an equally diverse method of entrapment is necessary. In most bacteria thus far examined, bacterial proteins (adhesins) act as receptors for carbohydrate epitopes expressed on mucins. Often, these interactions occur between selective sulphated or sialylated carbohydrate moieties. For example, in such diverse tissues as vagina, mouth and small intestine, Escherichia coli Type I, S and K88 fimbriae all recognize carbohydrate structures expressed on mucins as their cognate ligands (Erickson et al., 1992; Schroten et al., 1993; Venegas et al., 1995) . In addition, in the respiratory system both Staphylococcus aureus and Pseudomonas aeruginosa have been shown to bind to mucin carbohydrates (Scharfman et al., 1996; Trivier et al., 1997) . More recently, the bacteria that can cause ulcers, Helicobacter pylori, have been shown to be inhibited from binding to acidic glycosphingolipids on gastric epithelial cells by gastric sulphomucins (Veerman et al., 1997) . Even with the multitude of bacteria attempting colonization within the host, the diversity of carbohydrate chains expressed on mucin proteins severely limits the ability of different bacteria to escape capture, though certain bacteria are able to penetrate the mucus layer and interact directly with the surface of epithelial cells (Draper et al., 1980) . The method by which transmembrane mucins protect cells from bacterial infection is less clear, since these molecules would be expected to promote bacterial attachment to the mucosal surface. It is possible that binding to cell surface mucins still prevents binding to more proximal carbohydrate-bearing cell surface components, e.g. most glycoprotein receptors and gangliosides. It also is possible that bacterial binding stimulates release of mucin ectodomains, thereby preventing surface adherence.
The large, extended structures of cell surface mucins also limit accessibility to other cell surface components. The abundance of cell surface mucins, as well as the number of tandem repeat motifs, play important roles in such activities. Deletion of tandem repeat domains demonstrates that mucins must extend at least 50-200 nm from the cell surface to provide an effective barrier (Wesseling et al., 1996; Komatsu et al., 1997) . The presence and structure of oligosaccharide chains also play an important role in this regard. Inhibitors of O-linked oligosaccharide assembly cause production of mucin glycoproteins with truncated or aberrant structures (Kuan et al., 1989) . Uterine epithelial cells treated with such inhibitors display increased accessibility of apically disposed cell surface components to both carbohydrate ligands and enzymes (Valdizan et al., 1992) . Similarly, it is believed that the propensity of many tumour cells to express high levels of mucins aids in their protection from the host immune system (Sherblom and Moody, 1986; Devine and McKenzie, 1992; van de Weil-van Kemenade et al., 1993) . In addition to preventing sterically immune cells from attacking the tumour cell surface by steric hindrance, mucins also may repress immune cell activities or stimulate apoptosis of immune cells (Fung and Longenecker, 1991; Ogata et al., 1992; Gimmi et al., 1996) .
From the above, it can be reasoned that one result of high-level mucin expression is the creation of an enzymatically resistant, non-adhesive cell surface. In fact, mucins limit access to host cell receptors and severely impair cell-cell and cell-extracellular matrix adhesion Ligtenberg et al., 1992; Kemperman et al., 1994; Wesseling et al., 1995) . Paradoxically, mucins also may promote cell adhesion. Selectin ligands are carried by mucin glycoproteins Zhang et al., 1996) ; however, there is little evidence that selectin ligands occur or function physiologically at extravascular sites. Nonetheless, the presence of mucins does not necessarily imply nonadhesiveness, in all cases.
Mucin expression in the reproductive tract
Relatively little is known about mucin expression in the male reproductive tract. Among male reproductive tract tissues, the prostate has been studied most, in this regard. It is clear that both normal and malignant prostate epithelia display histologically detectable mucins (Gal et al., 1996) ; however, there is a shift from mucins bearing neutral oligosaccharides toward those bearing acidic oligosaccharides during conversion to a malignant state (Sentinelli, 1993; Goldstein et al., 1995) . Among integral membrane mucins, MUC1 is highly expressed in the prostate Gold et al., 1994) . Northern blot analyses failed to detect transcripts for the genes MUC2 or MUC3 encoding secreted mucins, in either normal or malignant prostate , although antibodies directed against a peptide motif of the tandem repeat region of MUC2 did react with this tissue (Durrant et al., 1994) . It is possible that MUC2 is transported to the prostate, or that protein bearing a related epitope occurs in this tissue. A recently discovered gene encoding a protein with multiple membrane-spanning domains and mucin-like regions, HE6, is highly expressed in the epididymis (Osterhoff et al., 1997) . Surprisingly, a few reports indicate that mucins (MUC8) are present on spermatozoa (D'Cruz et al., 1996) . It is possible that a mucin coat on spermatozoa might reduce sperm adhesion during its transit through the male and/or female reproductive tract. In fact, mucins have a significant effect on sperm transport through the cervical canal (as reviewed by Moghissi, 1972; Eriksen et al., 1998) .
Considerably more studies have been performed on mucin expression in the female reproductive tract, including ovaries, oviduct or Fallopian tube, uterus, cervix and vagina. The physiology and morphology, as well as glycoprotein biosynthetic capacity, of female reproductive tract tissues are strongly influenced by steroid hormones (Carson et al., 1990; Surveyor et al., 1995; Hoffman et al., 1998) . In addition, different regions of the female reproductive tract respond distinctly to steroid hormones. Therefore, knowledge of mucin expression in one region of the female reproductive tract is not necessarily predictive of expression in another region. In the complex tissue of the uterus, two types of epithelia, i.e. luminal and glandular, occur that also display regional distinctions. Thus, it is important to determine the stage of the oestrous or menstrual cycle from which tissues are prepared and, in the case of the uterus, the type of epithelium examined. These factors are not always clearly defined in the reports that have appeared.
Zona pellucida glycoproteins are produced in the ovary and surround mature ova (Wassarman and Litscher, 1995) . Several types of studies indicate that the oligosaccharides of these glycoproteins play key roles in spermatozoa-egg recognition (Wassarman, 1995; Wassarman and Litscher, 1995) . There is little information on other mucin glycoproteins expressed in the ovary. Mucin biosynthetic enzymes also are found in normal ovarian tissues (Yazawa et al., 1986) . Thus, the ovary is capable of assembling mucin glycoproteins; however, it is less clear whether mucin core proteins other than those for zona glycoproteins are expressed in this tissue. Conflicting reports have appeared on MUC1 expression in normal human ovary, perhaps due to differential specificities of the monoclonal antibodies used in these studies (Girling et al., 1989; Ho et al., 1993; Tashiro et al., 1994) . Little Muc1 expression has been observed in the mouse ovary using antibodies that recognize all forms of Muc1 protein retaining a cytoplasmic tail (J.Julian and D.D.Carson, unpublished observations). MUC2 does not appear to be expressed in the human ovary (Tashiro et al., 1994) . In contrast, it is generally observed that MUC1 as well as mucin-associated carbohydrate motifs are markedly elevated in malignant human ovarian tissue and cell lines (Girling et al., 1989; Yan et al., 1990; Ho et al., 1993; Tashiro et al., 1994) .
Unlike the ovary, the oviduct does typically express mucin genes in a non-transformed state. Of the eight human mucin genes cloned, the oviduct expresses only MUC1 in the epithelium . More recently, a secreted oviductal protein, that has mucin-like properties is proposed to represent a secretory-type mucin and has been tentatively designated as MUC9 (Lapensee et al., 1997) . The sequences of this mucin-like protein, oviductin, in rodents and humans displays the amino-acid tandem repeat motif common to mucins. However, this motif is extremely divergent in the sequence for the human protein and absent in large domestic species (Malette et al., 1995) . Unlike other mucin genes, which are often expressed in several tissues, oviductin is exclusive to the oviductal epithelium (Malette et al., 1995) . This largemolecular weight glycoprotein is extensively O-substituted, with approximately 50% or greater (depending on species) of the molecular mass contributed by carbohydrates. In all species thus far examined, oviductin has been found to be regulated by the ovarian steroid hormones. It is not known if either MUC1 or oviductin are regulated by steroidal hormones in humans. The functions of either of these mucin proteins within the oviduct is as yet unknown. Given that oviductin has been shown to interact with both the ovulated oocyte and spermatozoa as they traverse the oviduct, it has been postulated that this secreted glycoprotein may play a role in oocyte fertilization (Wassarman, 1995) . Recently, it has been postulated (Lapensee et al., 1997) that this protein may prevent ectopic pregnancy by covering the epithelial cells. The same role is possible for MUC1, given that it exhibits anti-adhesive characteristics in vitro. Clearly, more investigation into the roles of both mucins within the oviduct is necessary to determine their physiological functions.
A number of studies have appeared on mucin expression in the uterus. In all species examined to date, Muc1 is highly expressed in the uterus. Curiously, not all human endometrial cell lines express MUC1 and may even display ectopic expression of airway mucins (Gollub et al., 1993; Hey and Aplin, 1996) . This raises concern over the validity of using such cell lines for studies of regulation of mucin expression. In many species, Muc1 is downregulated in the luminal epithelium during the phase where embryo implantation normally occurs (Surveyor et al., 1995; Bowen et al., 1996; Hild Petito et al., 1996) . This has led to the suggestion that Muc1 serves as a barrier to embryo attachment under most conditions (Surveyor et al., 1995) . Rabbits also express very high levels of Muc1 during the receptive phase; however, Muc1 loss is restricted to the immediate site of embryo attachment, suggesting that an anti-adhesive function is conserved in this species (Hoffman et al., 1998) . The hypothesis that Muc1 prevents embryo attachment is supported by the demonstration that RU486 both inhibits embryo implantation and restores high-level Muc1 expression in mice (Surveyor et al., 1995) . Furthermore, while attachmentcompetent embryos fail to attach to polarized uterine epithelial cells in vitro (Valdizan et al., 1992) , they do so with high efficiency if mucins are removed enzymatically or if Muc1 is genetically ablated (DeSouza et al., 1999) . Maintenance of mucins at the apical surface of luminal uterine epithelial cells may provide protection from infection until the point at which the embryo is ready to attach. In fact, the uterus appears to be generically more susceptible to invasion during the 'receptive' phase, as transplanted tumour cells more effectively penetrate the endometrium at this time (Schlessinger, 1962; Maharajan and Maharajan, 1986) .
The major class of glycoproteins synthesized and expressed at the apical surface of polarized uterine epithelia in wild-type or Muc1 null mice is mucins (Valdizan et al., 1992; Surveyor et al., 1995) . Mucins also account for a major class of glycoproteins synthesized by polarized uterine epithelia of other species (Carson et al., 1988; Mani et al., 1992) . In contrast, mouse uterine epithelial cells cultured on tissue culture plastic primarily synthesize N-linked glycoproteins. Culture on matrigel-coated plastic is not sufficient to restore the normal pattern of predominantly mucin-type glycoprotein synthesis seen under polarizing conditions (Carson et al., 1988) . Therefore, adoption of a polarized state appears to be an important factor for mucin expression by uterine epithelia, although the mechanism underlying this response is not clear. Synthesis of mucins and many other classes of glycoproteins is strongly regulated by steroid hormones in the uterus. These responses are manifest both at the level of core protein mRNA expression and the activities of various glycosyltransferases (Carson et al., 1990 and references within; Surveyor et al., 1995) .
Muc1 accounts for less than 10% of the total complement of mucin oligosaccharides in mice (Pimental et al., 1996) . A comprehensive survey of mucin gene expression (MUC1-MUC7) revealed that only MUC1 and, to a lesser extent, MUC6 are expressed in the human uterus . A recently identified gene encoding a respiratory tract mucin, MUC8, has also been detected in human endometrium, although the expression of this gene varied considerably from patient to patient, perhaps due to differences in menstrual cycle phase (D'Cruz et al., 1993) . SMC also is expressed in rat uteri, although it is not clear if this occurs in other species (McNeer et al., 1998) . Antibodies recognizing a mucin-like glycoprotein of undefined core protein structure mouse ascites Golgi antigen or MAG also react well with human endometrial glands, with maximal reactivity during the receptive phase (Kliman et al., 1995) . It is not clear if the epitope recognized by MAG antibodies represent pure carbohydrate determinants found on many mucins, or peptide epitopes of known or novel mucin core proteins.
A number of studies have focused on MUC1 protein and mRNA expression using samples from women with well-defined cycle phases. These studies generally reveal that MUC1 levels increase during the mid-luteal (receptive) phase (Hey et al., 1994 (Hey et al., , 1995 Aplin et al., 1996) . Nonetheless, some studies with MUC1-specific monoclonal antibodies suggest that expression of some isoforms decreases during the receptive phase (Rye et al., 1993) . These studies primarily described expression in glandular epithelium, the major epithelial component of human uteri. Studies in the baboon revealed that patterns of glandular and luminal Muc1 expression are quite distinct (Hild-Petito et al., 1996) . Other differences were noted between luminal and glandular MUC1 expression in women undergoing hormonal regimens for oocyte donation (Meseguer et al., 1998a) . Recently, studies have been performed on human endometrial samples in the mid-proliferative (non-receptive) and mid-luteal (receptive) phases with clearly defined luminal epithelia (DeLoia et al., 1998) . These studies support the notion that MUC1 expression is maintained throughout the epithelia in the receptive phase in humans; however, as in the baboon, MUC1 shows regional specialization in terms of its pattern of expression. This specialization does not appear to occur at the level of MUC1 core protein expression, but rather at the level of carbohydrate modifications. Luminal and glandular epithelium becomes more modified with keratan sulphate and sialic acid residues during the receptive phase (Hoadley et al., 1990; Aplin et al., 1994) . Such modifications can mask certain MUC1 ectodomain epitopes (Ho and Kim, 1991; Devine and McKenzie, 1992; Ho et al., 1995) and may explain earlier, apparently conflicting, reports of MUC1 expression in women. Several monoclonal antibodies raised against the MUC1 core protein recognize similar epitopes within a sequence Pro-Asp-Thr-Arg-Pro in the tandem repeats (Meseguer et al., 1998b and references therein) . Glycosylation of the threonine within the epitope and/or adjacent threonines and serines reduces reactivity of some of these antibodies through steric hindrance (Aplin et al., 1998 and references therein) . For example, prior enzymatic deglycosylation increases the binding of the monoclonal antibody HMFG-1 to MUC1 in uterine sections (Aplin et al., 1998; DeLoia et al., 1998) . While the epitopes recognized by HMFG-1 and a related antibody HMFG-2 differ by only one amino acid (Pro-Asp-Thr-Arg and Asp-Thr-Arg respectively), reactivity of the latter appears not to be affected by glycosylation (DeLoia et al., 1998; Meseguer et al., 1998b) .
The function of the changes in MUC1 'glycoforms' at the uterine luminal surface is not clear. Modification with keratan sulphate would be expected to further enhance anti-adhesive function (Dou and Levine, 1995; Takahashi et al., 1996) , an undesirable property for an embryo attachment molecule. Presuming an anti-adhesive function with regard to embryo attachment in humans, MUC1 would have to be locally removed at the site of embryo attachment as occurs in rabbits (Hoffman et al., 1998) . An interesting counterproposal is that MUC1 may actually support embryo attachment. A recent report suggests a decrease in sulphation at the luminal surface during the receptive phase, implying less repulsion between the embryo and luminal epithelium (Aplin et al., 1998) . This proposal gains strength from observations that mucins can be selectin ligands (Lasky, 1992) and the detection of sialyl-Lewis X and A oligosaccharides in epithelial cells in receptive phase uteri and on MUC1 expressed by human uterine epithelial cell lines . Furthermore, L-selectin is expressed at early stages of preimplantation development in the human embryo (Campbell et al., 1995) . Studies in mice of carbohydrate motifs [lacto-N-fucopentaose-I (LNF-I)] potentially found on mucins also may support a role in embryo attachment (Lindenberg et al., 1988) . Studies focusing on the expression of LNF-I and selectin ligands at the luminal surface of human uterine epithelium, as well as the expression of adhesion molecules on the surface of human blastocyst stage embryos, will be required to resolve these issues. Studies in mice have revealed expression of specific cell surface oligosaccharides and lectins by attachment-competent blastocysts, as well as potential interacting molecules on the luminal surface of the receptive uterus (for reviews see Poirier and Kimber, 1997; Ghosh and Sengupta, 1998) .
In addition to MUC1, the human cervix also expresses several other mucin genes including MUC4, 5AC, 5B, MUC6 and MUC8 . In rabbits, cervical Muc1 levels do not vary more than 2-to 3-fold in response to steroid hormones, in marked contrast to the large (≥10-fold) changes seen in the uterus (Hewetson and Chilton, 1997; Hoffman et al., 1998) . Epithelia of both tissues express steroid hormone receptors and are strongly influenced by ovarian steroids. Therefore, this is a clear example of the tissue specificity of regulation of mucin expression. It is possible that steroid hormones modify the production of signals by underlying stroma that, in turn, regulate mucin production in the epithelium. Both MUC1 and MUC4 are expressed by human vaginal epithelium, although MUC4 expression is not observed in all cells of this tissue . Cycle (hormone)-dependent alterations in the production of cervical vaginal mucus is a well-described clinical phenomenon (Katz et al., 1997 and references therein); however, it is not clear if the source of the mucins in vaginal fluids is the vaginal tissue itself, or cells from tissues in the upper reproductive tract. Differences in mucin expression profiles along the female reproductive tract may explain in part the consistencies of the mucous gel in specific regions. For example, mucin concentration and mucous gel viscosity apparently are increased in the cervix during the ovulatory phase of the cycle (Wolf et al., 1977) . Not surprisingly, the cervix expresses many mucins having cysteine-rich sequences that may promote polymerization through intermolecular disulphide bonds, thereby increasing viscosity of the mucus layer (see Table III ). 
Summary and future directions
Based on ultrastructural studies, it has been appreciated for many years that the surfaces of mammalian reproductive tract mucosa are covered with a thick glycocalyx; however, only recently have mucin glycoproteins been identified at these surfaces. In many cases, particular mucin core proteins and oligosaccharide structures have been identified and changes in the pattern of expression observed in response to hormonal influences. Nonetheless, we still do not have a comprehensive picture of the spectrum of mucins expressed in any reproductive tract tissue. Furthermore, very little is known about the regulation of mucin gene expression either by these specific hormones or other factors. Understanding these molecular controls over mucin expression might provide new opportunities to modulate mucin expression in vivo. In the case of mucin functions as a barrier to infection, it may be desirable to develop methods to stimulate mucin expression as a prophylactic measure. In the case of embryo implantation, it may be desirable to develop means to reduce mucin expression following in-vitro fertilization-embryo transfer procedures to enhance success rates. The increasing availability of antibody and cDNA probes to mucin glycoproteins and genes, as well as the generation of various transgenic mice to study mucin expression and function, will be invaluable tools in the study of this interesting class of cell surface components.
Note added in Proof
Recently, SMC has been identified as MUC4.
